tiprankstipranks
Trending News
More News >
BioLineRX Ltd. (IL:BLRX)
:BLRX
Israel Market
Advertisement

Bioline Rx (BLRX) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
4Neutral
10Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
BioLineRX Ltd.’s (BLRX) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting BioLineRX Ltd. is a Sell.
BioLineRX Ltd.’s (BLRX) 20-Day exponential moving average is 2.13, while BioLineRX Ltd.’s (BLRX) share price is 2.1, making it a Sell.
BioLineRX Ltd.’s (BLRX) 50-Day exponential moving average is 2.23, while BioLineRX Ltd.’s (BLRX) share price is 2.1, making it a Sell.

Bioline Rx (BLRX) Pivot Points

Sep 12, 2025, 06:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.93
1.97
2.03
2.07
2.13
2.17
2.23
Fibonacci
1.97
2.00
2.03
2.07
2.10
2.13
2.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bioline Rx (BLRX) Moving Averages

Sep 12, 2025, 06:01 AM
Period
Simple
Exponential
MA5
2.08Buy
2.09Buy
MA10
2.09Buy
2.09Buy
MA20
2.11Sell
2.13Sell
MA50
2.29Sell
2.23Sell
MA100
2.29Sell
2.62Sell
MA200
3.05Sell
4.40Sell
BioLineRX Ltd.’s (BLRX) 10-Day exponential moving average is 2.09, while BioLineRX Ltd.’s (BLRX) share price is 2.1, making it a Buy.
BioLineRX Ltd.’s (BLRX) 100-Day exponential moving average is 2.62, while BioLineRX Ltd.’s (BLRX) share price is 2.1, making it a Sell.
BioLineRX Ltd.’s (BLRX) stock price is 2.1 and BioLineRX Ltd.’s (BLRX) 50-day simple moving average is 2.29, creating a Sell signal.
BioLineRX Ltd.’s (BLRX) stock price is 2.1 and BioLineRX Ltd.’s (BLRX) 100-day simple moving average is 2.29, creating a Sell signal.
BioLineRX Ltd.’s (BLRX) stock price is 2.1 and BioLineRX Ltd.’s (BLRX) 200-day simple moving average is 3.05, creating a Sell signal.

Bioline Rx (BLRX) Technical Indicators

Sep 12, 2025, 06:01 AM
Name
Value
Implied Action
RSI (14)
43.84
Neutral
STOCH (9,6)
27.78
Neutral
STOCHRSI (14)
27.78
Neutral
MACD (12,26)
-0.05
Sell
ADX (14)
19.85
Buy
Williams %R
-66.67
Buy
CCI (14)
110.03
Sell
ATR (14)
0.10
-
Ultimate Oscillator
38.15
Neutral
ROC
0.00
Sell
BioLineRX Ltd.’s (BLRX) Relative Strength Index (RSI) is 43.84, creating a Neutral signal.
BioLineRX Ltd.’s (BLRX) Trend Strength Indicator (ADX) is 19.85, creating a Buy signal.
BioLineRX Ltd.’s (BLRX) Commodity Channel Index (CCI) is 110.03, creating a Sell signal.

FAQ

Is BLRX a Buy, Hold, or Sell?
Based on BLRX’s technical indicators, BLRX is a Sell.
    What is BLRX’s RSI (14)?
    BLRX’s RSI (14) is 43.84, which suggests BLRX is a Neutral.
      What is BLRX’s MACD?
      BLRX’s MACD is -0.05, which suggests BLRX is a Sell.
        What is BLRX’s 5-day moving average?
        BLRX’s 5-day moving average is 2.08, which suggests BLRX is a Buy.
          What is BLRX’s 20-day moving average?
          BLRX 20-day moving average is 2.11, which suggests BLRX is a Sell.
            What is BLRX’s 50-day moving average?
            BLRX’s 50-day moving average is 2.29, which suggests BLRX is a Sell.
              What is BLRX’s 200-day moving average?
              BLRX’s 200-day moving average is 3.05, which suggests BLRX is a Sell.
                What is BLRX’s Williams % R (14)?
                BLRX’s Williams % R (14) is -66.67, which suggests BLRX is a Buy.
                  What is BLRX’s CCI (14)?
                  BLRX’s CCI (14) is 110.03, which suggests BLRX is a Sell.
                    What is the share price of BioLineRX Ltd.?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis